Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways

Article ID	Journal	Published Year	Pages	File Type
5847308	Vascular Pharmacology	2015	12 Pages	PDF

Keywords

MMP ECASS TNF r-TPA trial of org 10172 in acute stroke treatment HDL Alberta Stroke Program Early CT score NCCT MRS AIS Phorbol-12-myristate-13-acetate hsCRP NIHSS MPO PMA enzyme-linked immunosorbent assays neutrophil elastase inflammation hemorrhagic infarction Cerebrovascular disease hemorrhagic transformation Thrombolysis ELISA TOAST ASPECTS TIMP acute ischemic stroke Acute stroke tumor necrosis factor Recombinant tissue plasminogen activator Leukocytes high density lipoprotein National Institutes of Health stroke scale matrix metalloproteinase European cooperative acute stroke study Tissue inhibitor of metalloproteinase myeloperoxidase high sensitivity C-reactive protein

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways

Authors

Federico Carbone, Nicolas Vuilleumier, Maria Bertolotto, Fabienne Burger, Katia Galan, Gloria Roversi, Carmine Tamborino, Ilaria Casetta, Silva Seraceni, Alessandro Trentini, Franco Dallegri, Analina Raquel da Silva, Aldo Pende, Nathan Artom,